ivermectin living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 hospitalized
	COVID 19 hospitalized	COVID-19 mild to moderate	COVID-19 severe or critically
ivermectin	Gonzalez ...	Shahbaznejad Kirti I-TECH ... Chaccour Krolewiecki	Galan Galan
ivermectin plus doxycycline	Hashim A	NCT04523831 ...

43 studies excluded by filtering options 0

6064	Glorial F, 2020	1	10	0		not a RCT	risk of bias not avaialble
6079	NCT04422561 (Shouman), 2020	1	1	3			high risk of bias
6080	IDEA, 2020	2	10	0	excluded	not a RCT	risk of bias not avaialble
6082	ICON, 2020	0	13	0	selection pending
6083	IFORS (Pott-Junior), 2020	2	1	3	excluded		high risk of bias
6095	Camprubi, 2020	1	11	0		not a RCT	risk of bias not avaialble
6096	Elgazzar - treatment, 2020	2	1	3	excluded		high risk of bias
6097	Elgazzar - prophylaxis, 2020	2	1	3	excluded		high risk of bias
6098	Patel, 2020	2	10	0	excluded	not a RCT	risk of bias not avaialble
6099	Chowdhury A, 2020	1	1	3			high risk of bias
6134	Morgenstern, 2020	2	30	0	excluded	not a RCT	risk of bias not avaialble
6321	Podder, 2020	1	1	3			high risk of bias
6368	Niaee (vs placebo), 2020	2	1	3	excluded		high risk of bias
6369	Ahmed, 2020	1	1	3			high risk of bias
6370	Chachar, 2020	1	1	3			high risk of bias
6372	Alam, 2020	0	31	3	selection pending
6373	Behera, 2020	1	20	0		not a RCT	risk of bias not avaialble
6374	NCT04425850 (Caravallo), 2020	2	31	0	excluded	not a RCT	risk of bias not avaialble
6375	Cadegiani -Iver, 2020	2	99	0	excluded	not a RCT	risk of bias not avaialble
6379	Chamie-Quintero,, 2020	2	15	0	excluded	not a RCT	risk of bias not avaialble
6381	Espitia-Hernandez, 2020	1	31	0		not a RCT	risk of bias not avaialble
6381	Espitia-Hernandez, 2020	1	31	0		not a RCT	risk of bias not avaialble
6382	Khan, 2020	0	13	0	selection pending
6382	Khan, 2020	0	13	0	selection pending
6383	Soto-Becerra, 2020	0	12	2	selection pending
6383	Soto-Becerra, 2020	0	12	2	selection pending
6384	Spoorthi, 2020	1	31	0		not a RCT	risk of bias not avaialble
6384	Spoorthi, 2020	1	31	0		not a RCT	risk of bias not avaialble
6449	Okumuş, 2020	1	1	3			high risk of bias
6491	Ivercar-Tuc, 2021	1	1	3			high risk of bias
6575	Bukhari, 2021	1	1	3			high risk of bias
6624	Babalola, 2021	1	1	3			high risk of bias
6625	Nasir, 2020	2	31	0	excluded	not a RCT	risk of bias not avaialble
6625	Nasir, 2020	2	31	0	excluded	not a RCT	risk of bias not avaialble
6626	RIVET-COV (Mohan) (12mg and 24mg), 2021	1	1	3			high risk of bias
7313	Abd-Elsalam, 2021	1	1	3			high risk of bias
7314	Samaha, 2021	2	1	3	excluded		high risk of bias
7995	Hazan, 2021	2	32	0	excluded	not a RCT	risk of bias not avaialble
8283	Chahla, 2021	1	3	3			high risk of bias
8328	Behera, 2021	0	13	0	selection pending
9462	Mayer, 2022	0	0	0	selection pending
10322	Elgazzar, 0	2	0	0	excluded		risk of bias not avaialble
10323	Seet 2021, 2021	1	1	3			high risk of bias